References
- Strickler JG, Michie SA, Warnke RA, Dorfman RF. The “syncytial variant” of nodular sclerosing Hodgkin's disease. Am J Surg Pathol. 1986;10:470–477. doi:10.1097/00000478-198607000-00004. PMID:2425645.
- Sethi T, Nguyen V, Li S, et al. Differences in outcome of patients with syncytial variant Hodgkin lymphoma compared with typical nodular sclerosis Hodgkin lymphoma. Ther Adv Hematol. 2017;8:13–20. doi:10.1177/2040620716676256. PMID:28042455.
- Ben-Yehuda-Salz D, Ben-Yehuda A, Polliack A, et al. Syncytial variant of nodular sclerosing Hodgkin's disease. A new clinicopathologic entity. Cancer. 1990;65:1167–1172. doi:10.1002/1097-0142(19900301)65:5<1167::AID-CNCR2820650523>3.0.CO;2-V. PMID:2406009.
- Schwartz CL, Constine LS, Villaluna D, et al. A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate and high-risk Hodgkin lymphoma: the results of P9425. Blood. 2009;114:2051–2059. doi:10.1182/blood-2008-10-184143. PMID:19584400.